Sandra Levy
ARTICLES BY THIS AUTHOR
- 5/18/2020
Alembic gets FDA OK for 2 generics
Clobetasol propionate shampoo 0.05% had an estimated market value of $28 million, and Doxycycline Hyclate tablets 100 mg had a market value of roughly $53 million, for the 12 months ended December 2019. - 5/18/2020
FDA approves new indication for AstraZeneca’s Farxiga
AstraZeneca's Farxiga provides a treatment option for heart failure patients with reduced ejection fraction. - 5/18/2020
Lupin debuts authorized generic of Apriso
Apriso had a market value of approximately $290 million, according to March 2020 IQVIA data. - 5/17/2020
AAM files amicus brief supporting biosimilars pathway
An Association for Accessible Medicines amicus brief argues that even if the individual mandate of the Affordable Care Act is deemed unconstitutional, the biosimilars pathway should remain intact. - 5/17/2020
Micro Labs, Saptalis debut generic Riomet
Riomet had a market value of $15 million in 2019, according to IQVIA. - 5/14/2020
NACDS report outlines pharmacy's role in reopening the country
NACDS' new report urges national and state leaders to ensure that pharmacists and pharmacies are fully utilized to provide essential services and support to the national effort to combat the COVID-19 pandemic. - 5/13/2020
Gilead strikes deal with 5 generic firms to expand remdesivir supply
Gilead has inked deals with Cipla, Ferozsons Laboratories, Hetero Labs, Jubilant Lifesciences and Mylan to manufacture remdesivir for distribution in 127 countries. - 5/13/2020
CVS Health to open 1,000 COVID-19 drive-thru test sites by end of May
CVS Health expects to have up to 1,000 drive-thru COVID-19 testing site locations by the end of May, with the goal of processing up to 1.5 million tests per month. - 5/13/2020
NCPA joins push for additional economic recovery assistance
NCPA is joining the America’s Recovery Fund Coalition, which is advocating for longer-term federal support for businesses and pharmacies. - 5/13/2020
HRG, PHT complete small dispenser DSCSA pilot study
The Drug Supply Chain Security Act pilot study underscored that most pharmacists were unaware of many of the requirements and needed assistance in carrying out best practice and process implementation.
